A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Rimouski, Boston MA, New Haven CT, Quebec,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase3, Recruiting
Active & Responsive
TReating Incontinence for Underlying Mental and Physical Health
for
Urinary Incontinence, Urge, Urinary Incontinence,
Location: Palo Alto CA, San Francisco CA
Sponsor: University of California, San Francisco
Sex: Female
Age: 60+
Code: NCT05362292
Recruiting
Active & Responsive
Evaluation of RSB11-HI Postbiotic Supplementation for Supporting Weight Management, Metabolic Wellness, and Quality of Life in Healthy Adults
for
Healthy Adults
Location: Dallas TX
Sponsor: Able Biolabs, LLC
Sex: All
Age: 18 - 55
Code: NCT07788833
Recruiting
Active & Responsive
A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers
for
Healthy Volunteer
Location: New Haven CT
Sponsor: Ratio Therapeutics, Inc.
Sex: All
Age: 18 - 60
Code: NCT07774650
Early_phase1, Recruiting
Active & Responsive
Pregnancy Supplement Study in Healthy Pregnant Women
for
Pregnancy
Location: Chicago IL
Sponsor: Perelel Inc.
Sex: Female
Age: 21 - 40
Code: NCT07226414
Recruiting
Active & Responsive
Phase 1 Study of Intravaginal KB15A
for
Healthy Subjects
Location: Norfolk VA
Sponsor: ZabBio Inc.
Sex: Female
Age: 18 - 45
Code: NCT07222020
Phase1, Recruiting
Active & Responsive
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old